Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to evaluate, by means of a specific cognitive test battery
(Brief Repeatable Battery and Delis-Kaplan Executive Function System scale), the
slowing/reduction of cognitive dysfunction progression in RRMS patients after 18 months of
treatment with fingolimod in comparison with interferon beta 1b treatment, and to evaluate
which test of the battery is the most sensitive in detecting differences between treatment
groups.